SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-313873
Filing Date
2020-12-09
Accepted
2020-12-09 16:43:52
Documents
4
Period of Report
2020-12-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d10551d8k.htm 8-K 23724
2 EX-10.1 d10551dex101.htm EX-10.1 16019
3 EX-99.1 d10551dex991.htm EX-99.1 10320
4 GRAPHIC g10551g91t63.jpg GRAPHIC 3214
  Complete submission text file 0001193125-20-313873.txt   55993
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39311 | Film No.: 201378302
SIC: 2834 Pharmaceutical Preparations